1-6 of 6
Marco Campioni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Andrzej Jakubowiak, MD PhD, Istvan Matyas Majer, PhD, Ivan Houisse, MSc, Agnes Benedict, Marco Campioni, Sumeet Panjabi, Sikander Ailawadhi, MD
Journal: Blood
Blood (2016) 128 (22): 3582.
https://doi.org/10.1182/blood.V128.22.3582.3582
Published: 2016
Journal Articles

Exploration of Survival Stratification of Patients with Multiple Myeloma after First Relapse Using Real World Data

Roman Hájek, Jiri Jarkovsky, MSc, PhD, Walter Bouwmeester, Maarten Treur, Lucy DeCosta, Marco Campioni, Michel Delforge, Marc S. Raab, MD, Paul Schoen, Zsolt Szabo, MD, Brozova Lucie, Sebastian Gonzalez-McQuire
Journal: Blood
Blood (2016) 128 (22): 2417.
https://doi.org/10.1182/blood.V128.22.2417.2417
Published: 2016
Journal Articles

The Value of Risk Stratification Tools in Multiple Myeloma (MM) in the Real-World: Validation of the Revised- International Staging System (R-ISS) at Initiation of Treatment and Relevance of the ISS and the R-ISS for Risk Stratification in the Relapsed Setting Using Data from the Czech Registry of Monoclonal Gammopathies (RMG)

Roman Hájek, Jiri Jarkovsky, MSc, PhD, Walter Bouwmeester, Maarten Treur, DeCosta Lucy, Marco Campioni, Michel Delforge, Marc S. Raab, MD, Paul Schoen, Zsolt Szabo, MD, Sebastian Gonzalez-McQuire
Journal: Blood
Blood (2016) 128 (22): 2418.
https://doi.org/10.1182/blood.V128.22.2418.2418
Published: 2016
Journal Articles

Indirect Comparisons to Assess the Relative Efficacy of Carfilzomib + Lenalidomide + Dexamethasone Versus Panobinostat + Bortezomib + Dexamethasone and Bortezomib + Dexamethasone: A Matching Adjusted Indirect Comparison

Michael Rael, PhD, Agnes Benedict, Jack Ishak, Sarah Cadarette, Marco Campioni, Sumeet Panjabi
Journal: Blood
Blood (2015) 126 (23): 5622.
https://doi.org/10.1182/blood.V126.23.5622.5622
Published: 2015
Journal Articles

Indirect Comparison to Assess the Relative Efficacy of Carfilzomib + Lenalidomide + Dexamethasone Versus Bortezomib + Thalidomide + Dexamethasone: A Matching Adjusted Indirect Comparison

Michael Rael, PhD, Agnes Benedict, Jack Ishak, Sarah Cadarette, Marco Campioni, Sumeet Panjabi
Journal: Blood
Blood (2015) 126 (23): 5624.
https://doi.org/10.1182/blood.V126.23.5624.5624
Published: 2015
Journal Articles

Cost per Treatment Success of Thrombopoietin Receptor Agonists Vs "Watch and Rescue" Strategy for Treating Adult Non-Splenectomized Patients with Chronic Immune Thrombocytopenia: A US Payer Perspective

Xiaoyan Li, PhD, Anjali Sharma, MD, Xinke Zhang, MS, Marco Campioni, PhD, Kelly Fust, MS, Junji Lin, PhD, Anju Parthan, PhD, Xuena Wang, PhD, Richard Zur, PhD, Karynsa Cetin, MPH, Melissa Eisen, MD
Journal: Blood
Blood (2015) 126 (23): 4461.
https://doi.org/10.1182/blood.V126.23.4461.4461
Published: 2015